Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer

E-ISSN： 1875-5992|12|8|982-987

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.12, Iss.8, 2012-10, pp. : 982-987

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Status of Primary Cytoreductive Surgery for the Treatment of Advanced Epithelial Ovarian Cancer

Current Cancer Therapy Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 67-79

Bentham Science Publishers

Access to resources Recommend Favorite

The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer

By Karagol Hakan Saip Pinar Uygun Kazim Caloglu Murat Eralp Yesim Tas Faruk Aydiner Adnan Topuz Erkan

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 39-43

Humana Press, Inc

Access to resources Recommend Favorite

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients

By Romanini A. Tanganelli L. Carnino F. Fanucchi A. Lionetto R. Pastorino S. Cosio S. Gadducci A. Conte P.F.

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 354-359

Elsevier

Access to resources Recommend Favorite

A Phase 2 Study with Epirubicin as Second-Line Treatment of Patients with Advanced Epithelial Ovarian Cancer

By Havsteen H. Bertelsen K. Gadeberg C.C. Jacobsen A. Kamby C. Sandberg E. Sengelov L.

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 210-215

Academic Press

Access to resources Recommend Favorite

Bevacizumab treatment and quality of life in advanced ovarian cancer

By Canevari Silvana Raspagliesi Francesco Lorusso Domenica

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 951-954

Future Medicine

Access to resources Recommend Favorite